Studies show shear wave elastography as potential tool for predicting implantation outcomes, determine risk factors for pregnancy loss, and reveal the rarity of recurrent implantation failure and consecutive pregnancy loss
BASKING RIDGE, N.J., Oct. 18, 2023 /PRNewswire/ -- IVIRMA Global, the largest reproductive medicine group in the world, has a long history of pioneering research in the field of assisted reproductive technologies that has led to major advances in assisted reproduction. Many of today's standard practices, including elective single embryo transfer and preimplantation genetic testing for aneuploidy, have been shaped by the fertility group's innovative research efforts.
At the recently concluded American Society of Reproductive Medicine (ASRM) 2023 conference in New Orleans, investigators from the IVIRMA Global Research Alliance contributed further to the field, presenting 37 separate studies addressing clinically important questions that will continue to improve outcomes and help patients successfully grow their families.
Researchers from Reproductive Medicine Associates (RMA), the U.S. arm of IVIRMA Global, presented new research that could change fertility specialists' understanding of the factors impacting successful implantation, pregnancy and live birth.
"Cultivating new knowledge through the research conducted at RMA offers practitioners invaluable insights into the complexities associated with reproductive medicine in order to provide evidence-based clinical care to their patients," said Dr. Emre Seli, Director of Research for IVIRMA in the U.S.
Read More: PRNewswireNews - Jornalwebdigital
0 Comments